 1-JUN-1987 09:46:27.25

SCHERING-PLOUGH <SGP> GETS FDA APPROVAL

Schering-Plough Corp said its Elocon topical steroid for inflammatory skin disorders has been approved for marketing by the U.S. Food and Drug Administration in cream and ointment forms for once-daily applications.     The company said overseas health agency registrations for Elocon are scheduled to be submitted in a number of major markets this year and in other areas in 1988.  Reuter &#3;

